Literature DB >> 29761634

Extracephalic manifestations of nonchromosomal, nonsyndromic holoprosencephaly.

Ariel F Martinez1, Paul S Kruszka1, Maximilian Muenke1.   

Abstract

Nonchromosomal, nonsyndromic holoprosencephaly (NCNS-HPE) has traditionally been considered as a condition of brain and craniofacial maldevelopment. In this review, we present the results of a comprehensive literature search supporting a wide spectrum of extracephalic manifestations identified in patients with NCNS-HPE. These manifestations have been described in case reports and in large cohorts of patients with "single-gene" mutations, suggesting that the NCNS-HPE phenotype can be more complex than traditionally thought. Likely, a complex network of interacting genetic variants and environmental factors is responsible for these systemic abnormalities that deviate from the usual brain and craniofacial findings in NCNS-HPE. In addition to the systemic consequences of pituitary dysfunction (as a direct result of brain midline defects), here we describe a number of extracephalic findings of NCNS-HPE affecting various organ systems. It is our goal to provide a guide of extracephalic features for clinicians given the important clinical implications of these manifestations for the management and care of patients with HPE and their mutation-positive relatives. The health risks associated with some manifestations (e.g., fatty liver disease) may have historically been neglected in affected families. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  NAFLD; SHH pathway; congenital heart defect; extracephalic manifestations; fatty liver disease; gastrointestinal anomaly; genitourinary anomaly; holoprosencephaly; neural tube defect; skeletal anomaly

Mesh:

Substances:

Year:  2018        PMID: 29761634      PMCID: PMC6125181          DOI: 10.1002/ajmg.c.31616

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  137 in total

1.  Hedgehog signaling plays a conserved role in inhibiting fat formation.

Authors:  Jae Myoung Suh; Xiaohuan Gao; Jim McKay; Renee McKay; Zack Salo; Jonathan M Graff
Journal:  Cell Metab       Date:  2006-01       Impact factor: 27.287

2.  Arteries define the position of the thyroid gland during its developmental relocalisation.

Authors:  Burkhard Alt; Osama A Elsalini; Pamela Schrumpf; Nele Haufs; Nathan D Lawson; Georg C Schwabe; Stefan Mundlos; Annette Grüters; Heiko Krude; Klaus B Rohr
Journal:  Development       Date:  2006-10       Impact factor: 6.868

3.  NOTCH, a new signaling pathway implicated in holoprosencephaly.

Authors:  Valérie Dupé; Lucie Rochard; Sandra Mercier; Yann Le Pétillon; Isabelle Gicquel; Claude Bendavid; Georges Bourrouillou; Usha Kini; Christel Thauvin-Robinet; Timothy P Bohan; Sylvie Odent; Christèle Dubourg; Véronique David
Journal:  Hum Mol Genet       Date:  2010-12-31       Impact factor: 6.150

4.  Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus.

Authors:  J Motoyama; J Liu; R Mo; Q Ding; M Post; C C Hui
Journal:  Nat Genet       Date:  1998-09       Impact factor: 38.330

5.  Evidence for the involvement of the Gli gene family in embryonic mouse lung development.

Authors:  J C Grindley; S Bellusci; D Perkins; B L Hogan
Journal:  Dev Biol       Date:  1997-08-15       Impact factor: 3.582

6.  Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary.

Authors:  J Ericson; S Norlin; T M Jessell; T Edlund
Journal:  Development       Date:  1998-03       Impact factor: 6.868

Review 7.  Holoprosencephaly: a paradigm for the complex genetics of brain development.

Authors:  E Roessler; M Muenke
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

8.  Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly.

Authors:  Erich Roessler; Maia V Ouspenskaia; Jayaprakash D Karkera; Jorge I Vélez; Amy Kantipong; Felicitas Lacbawan; Peter Bowers; John W Belmont; Jeffrey A Towbin; Elizabeth Goldmuntz; Benjamin Feldman; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2008-06-05       Impact factor: 11.025

9.  Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function.

Authors:  F Lacbawan; B D Solomon; E Roessler; K El-Jaick; S Domené; J I Vélez; N Zhou; D Hadley; J Z Balog; R Long; A Fryer; W Smith; S Omar; S D McLean; K Clarkson; A Lichty; N J Clegg; M R Delgado; E Levey; E Stashinko; L Potocki; M I Vanallen; J Clayton-Smith; D Donnai; D W Bianchi; P B Juliusson; P R Njølstad; H G Brunner; J C Carey; U Hehr; J Müsebeck; P F Wieacker; A Postra; R C M Hennekam; M-J H van den Boogaard; A van Haeringen; A Paulussen; J Herbergs; C T R M Schrander-Stumpel; A R Janecke; D Chitayat; J Hahn; D M McDonald-McGinn; E H Zackai; W B Dobyns; M Muenke
Journal:  J Med Genet       Date:  2009-04-02       Impact factor: 6.318

Review 10.  GLI2 mutations as a cause of hypopituitarism.

Authors:  Laurie E Cohen
Journal:  Pediatr Endocrinol Rev       Date:  2012-08
View more
  2 in total

1.  Mutations in phospholipase C eta-1 (PLCH1) are associated with holoprosencephaly.

Authors:  Ichrak Drissi; Emily Fletcher; Ranad Shaheen; Michael Nahorski; Amal M Alhashem; Steve Lisgo; Alberto Fernández-Jaén; Katherine Schon; Kalthoum Tlili-Graiess; Sarah F Smithson; Susan Lindsay; Hayley J Sharpe; Fowzan S Alkuraya; Geoff Woods
Journal:  J Med Genet       Date:  2021-04-05       Impact factor: 6.318

2.  New SHH and Known SIX3 Variants in a Series of Latin American Patients with Holoprosencephaly.

Authors:  Viviane Freitas de Castro; Daniel Mattos; Flavia Martinez de Carvalho; Denise Pontes Cavalcanti; Milagros M Duenas-Roque; Juan Llerena; Viviana Raquel Cosentino; Rachel Sayuri Honjo; Julio Cesar Loguercio Leite; Maria Teresa Sanseverino; Márcia Pereira Alves de Souza; Pricila Bernardi; Ana Maria Bolognese; Luiz Carlos Santana da Silva; Pablo Barbero; Patricia Santana Correia; Larissa Souza Mario Bueno; Clarice Pagani Savastano; Iêda Maria Orioli
Journal:  Mol Syndromol       Date:  2021-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.